FDA grants emergency use authorization for PHASE Scientific International’s new OTC Indicaid COVID-19 single-use rapid flow immunoassay antigen at-home test; test provides results in about 20 minutes

March 22, 2022 (press release) –

The Food and Drug Administration last week authorized for emergency use a new over-the-counter COVID-19 test. The INDICAID COVID-19 Rapid Antigen At-Home Test provides results in about 20 minutes. For more on the test, see the fact sheet for health care providers.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.